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Summary
Sex is determined in C. elegans by a chromosome-
counting mechanism that tallies X chromosome dose
relative to the sets of autosomes, the X:A ratio. A
group of genes on X called X signal elements (XSEs)
communicates X chromosome number by repressing
the activity of the master sex-determination switch
gene xol-1 in a dose-dependent manner. xol-1 is re-
pressed by transcriptional and posttranscriptional
mechanisms and is inactive in XX animals (hermaph-
rodite) but active in XO animals (male). Prior to our
work, the nature of the autosomal signal and its tar-
get(s) were unknown. Here we show the signal in-
cludes discrete, trans-acting autosomal signal ele-
ments (ASEs) that counter XSEs to coordinately
control both sex determination and dosage compen-
sation. sea-1, the first autosomal signal element, en-
codes a T-box transcription factor that opposes XSEs
by activating transcription of xol-1. Hence, xol-1 in-
tegrates both X and autosomal signals to determine
sexual fate.
Introduction
Dose-sensitive signals play essential roles in cell fate
decisions during development. Small changes in the
concentration of key regulators are translated into dra-
matically different developmental fates. A prime exam-
ple is sex determination. In C. elegans and D. melano-
gaster, a set of dose-sensitive genes on X called X
signal elements (XSEs) communicates X chromosome
number to determine sex (Cline and Meyer, 1996). The
single dose of XSEs present in diploid XO animals
specifies male fate, while the double dose in diploid XX
animals specifies female (or hermaphrodite) fate. XSEs
relay X chromosome dose by controlling the activity of
a master sex-determination switch gene. In C. elegans,
that target is xol-1 (XO lethal) (Miller et al., 1988; Rhind
et al., 1995). xol-1 is repressed by the double dose of
XSEs in XX animals through transcriptional and post-
transcriptional mechanisms, thereby inducing hermaph-
rodite development, which includes activation of the
dosage compensation machinery (Figure 1A; Carmi et
al., 1998; Carmi and Meyer, 1999; Nicoll et al., 1997).*Correspondence: bjmeyer@berkeley.edu
1Present address: Department of Molecular Biology, Massachu-
setts General Hospital, Wellman 10, 50 Blossom Street, Boston,
Massachusetts 02114.The single dose of XSEs in XO embryos fails to repress
xol-1. Active xol-1 induces male development.
Rather than measuring the absolute number of X
chromosomes, C. elegans assesses the number of X
chromosomes relative to the ploidy, the number of sets
of autosomes (Madl and Herman, 1979). Although two
X chromosomes dictate hermaphrodite development in
a diploid animal (X:A of 1.0), they dictate male develop-
ment in a tetraploid (X:A of 0.5). This counting process
is remarkably discriminating. An X:A signal of 0.67 (XX
triploid) reliably induces male development, and just as
reliably, a signal of 0.75 (XXX tetraploid) induces her-
maphrodite development.
Our goal was to discover the signals that communi-
cate ploidy during the sex determination process. At
the outset, no information was known about the nature
of the autosomal signal or its target(s). A critical ques-
tion was whether a set of dose-sensitive genes on au-
tosomes relays autosomal dose in a manner analogous
to that of X signal elements.
The distinguishing genetic feature of XSEs is the re-
ciprocal, sex-specific phenotypes caused by changing
their dose in XX and XO diploid animals (Figure 1B;
Carmi and Meyer, 1999). Decreasing XSE dose specific-
ally kills hermaphrodites but not males, while increas-
ing XSE dose kills males but not hermaphrodites.
Decreasing XSE dose in XX animals blocks xol-1 re-
pression. The active xol-1 product then masculinizes
XX animals and kills them by preventing the activation
of dosage compensation, the vital process that equal-
izes levels of X chromosome products between sexes.
C. elegans dosage compensation is achieved by an XX-
specific protein complex that binds both X chromo-
somes of hermaphrodites to reduce X expression by
half (Chan et al., 2004; Chuang et al., 1994; Csankovszki
et al., 2004; Meyer and Casson, 1986). XX animals ex-
pressing xol-1 are unable to form an active dosage
compensation complex and hence die from overex-
pression of X-linked genes. Conversely, increasing the
dose of XSEs in XO animals represses xol-1, causing
activation of dosage compensation and male lethality
from underexpression of X-linked genes. Since the mul-
tiple XSEs function together to repress xol-1, altering
the dose of any single XSE does not necessarily pro-
duce a visible phenotype (Carmi and Meyer, 1999).
However, combinations of two or more XSE mutations
cause severe synergistic sex determination and dosage
compensation defects. The XSE called fox-1 encodes
an RNA binding protein that controls xol-1 posttran-
scriptionally, and the XSE called sex-1 encodes a nu-
clear receptor that controls xol-1 transcriptionally. Both
the transcriptional and posttranscriptional modes of
regulation are required to repress xol-1 fully in XX an-
imals.
Autosomal signal elements (ASEs) would be ex-
pected to counter the action of XSEs and thereby have
opposite effects: increasing ASE dose would harm her-
maphrodites, while reducing ASE dose would harm
males. However, the autosomal signal need not be
composed of discrete autosomal signal element genes
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340Figure 1. Identification and Characterization of the Autosomal
Component of the C. elegans X:A Sex Determination Signal
(A) Genetic hierarchy regulating sex determination and dosage
compensation. The ratio of X chromosomes to sets of autosomes
is the primary signal that determines sexual fate and the level of
X chromosome gene expression. In XX diploids (2X:2A), xol-1 is
repressed, permitting high expression of sdc-2, the pivotal XX-spe-
cific trigger of dosage compensation and hermaphrodite develop-
ment. In XO diploids (1X:2A), xol-1 is active and sdc-2 is repressed,
permitting male development. The dosage compensation ma-
chinery is inactive in males. A group of X-linked genes called X
signal elements (XSEs) communicates X chromosome dose by re-
pressing xol-1 when they are present in two doses but not in one
dose. The autosomal signal must oppose the X signal, but prior to
our current work, the nature of the autosomal signal was not
known. A key question was whether a group of discrete, dose-
sensitive autosomal signal elements (ASEs) communicates autoso-
mal dose in a manner analogous to XSEs.
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yranscription factor that opposes XSEs by activating
B) Predicted outcomes from changing the dose of X and autoso-
al signal elements in 2X:2A and 1X:2A animals. Mutations in X
ignal elements cause sex-specific, dose-dependent phenotypes.
X animals with xse mutations die from the disruption of dosage
ompensation, and the survivors are masculinized and dumpy
Dpy). Mutations in potential autosomal signal elements (ASEs)
hould also cause synergistic, dose-dependent phenotypes, but
nes opposite to those caused by XSE mutations. Moreover, since
he sex determination signal is the ratio of X chromosomes to au-
osomes, a decrease in the dose of ASEs in XX animals is predicted
o compensate for a decrease in the dose of XSEs by restoring the
verall balance of the perceived X:A signal. Conversely, an increase
n the dose ASEs in XO animals should compensate for an increase
n XSEs. Furthermore, an increase in the dose of ASEs in XX ani-
als should enhance the mutant phenotype caused by a decrease
n XSEs, and a decrease in the dose of ASEs in XO animals should
nhance the mutant phenotype caused by an increase in XSEs. In
he figure, a decrease in the dose of either XSEs or ASEs is repre-
ented by a downward arrow, and an increase in XSE or ASE dose
s represented by an upward arrow. If the change in signal element
ose is masculinizing, the arrow is aqua; if the change is feminizing,
he arrow is fuchsia.
C) Genetic screen for mutations in ASE genes. The viability of her-
aphrodites doubly mutant for the XSEs fox-1 sex-1 depends on
Ex483[Pdpy-30::sdc-2(+)], a mitotically unstable extrachromo-
omal array that overexpresses sdc-2(+) constitutively from a pro-
oter insensitive to the X:A signal. This array, referred to as
Ex[sdc-2(+)] in the figure, also carries the marker myo-2::gfp,
hich causes the pharynx to be green. Following mutagenesis with
MS, mutations that suppress fox-1 sex-1 lethality can be recov-
red from hermaphrodites that acquire the ability to live in the ab-
ence of the rescuing array and therefore do not have a green phar-
nx. These are candidate loss-of-function mutations in ASEs.hat produce trans-acting products. Instead, the au-
osomal signal could be an indirect reflection of chro-
osome number, which changes with ploidy. For exam-
le, as chromosome number increases, so does the
oncentration of nonspecific DNA sites that might bind
SEs with low affinity. An increase in such sites would
educe XSE binding to bona fide target sites within xol-1,
hereby disrupting repression of xol-1. Alternatively, the
utosomal signal might act more specifically to counter
SEs, but be composed of discrete elements that act
n cis, unlike XSEs, which act in trans. For example, the
utosomal signal could include high-affinity, cis-acting
inding sites for XSEs, which would titrate XSEs away
rom their xol-1 targets, thereby activating xol-1.
Like the X signal, the autosomal signal could regulate
he master sex switch gene xol-1, the target of XSEs.
lternatively, downstream genes in the sex determina-
ion and dosage compensation pathway might interpret
he autosomal signal (Figure 1A). The autosomal signal
ight act like the X signal to coordinately control both
ex determination and dosage compensation by regu-
ating a single target gene that directs both processes,
r it might act instead on more specialized targets to
ontrol the two processes independently.
Our work reveals the genetic and molecular character
f the autosomal signal in C. elegans sex determina-
ion. The autosomal signal includes discrete, trans-act-
ng ASEs that counter XSEs to coordinately control
oth sex determination and dosage compensation.
urthermore, sea-1 (signal element on an autosome),
he first ASE identified in C. elegans, encodes a T-box
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341transcription of xol-l, thereby inducing male develop-
ment. Hence, xol-1 integrates both X and autosomal
signals to determine sexual fate.
Results and Discussion
Genetic Screen for Autosomal Signal Elements
To isolate loss-of-function mutations in potential ASE
genes, we designed a sensitized genetic screen that
took advantage of the synergistic behavior of X chro-
mosome signal elements (Figure 1C). Although XX ani-
mals carrying a null mutation in the XSE fox-1 have no
obvious phenotype and XX animals carrying a null mu-
tation in the XSE sex-1 have only reduced viability, all
XX animals homozygous for both null mutations, fox-
1(y303) and sex-1(y263), die from the failure to assem-
ble the dosage compensation complex on X (Figures
2A and 2B; Carmi et al., 1998; Nicoll et al., 1997). We
reasoned that disruption of an ASE gene, even one with
a small contribution to the autosomal signal, would
help restore the X:A balance and hence suppress the
XX lethality, at least in part (Figure 1B).
For the screen, fox-1 sex-1 doubly mutant hermaph-
rodites were maintained as a viable strain by a trans-
genic array that ectopically expresses sdc-2(+) from the
non-sex-specific promoter dpy-30. SDC-2 produced
from yEx483[Pdpy-30::sdc-2(+)] induces assembly of
the dosage compensation complex on X chromosomes
independent of either the X:A signal or level of xol-1
expression (Dawes et al., 1999). The array also carries
the myo-2::gfp transformation marker, which causes
the pharynx to be green. The 55% of fox-1 sex-1 prog-Figure 2. A sea-1 Mutation Permits the Dos-
age Compensation Complex to Assemble
onto the X Chromosomes of fox-1 sex-1 XX
Mutant Embryos
Confocal images of mutant or wild-type XX
embryos at approximately the 100-cell stage,
costained with antibodies against the dosage
compensation proteins DPY-27 (green) and
SDC-3 (red) and with DAPI (blue), a DNA-inter-
calating dye.
(A) In wild-type XX embryos, DPY-27 and
SDC-3 localize specifically to X chromo-
somes.
(B) In fox-1 sex-1 mutant embryos, the dos-
age compensation complex cannot assem-
ble on X, causing XX animals to die from
overexpression of X-linked genes. In these
mutants, SDC-3 is absent and DPY-27 is
greatly reduced in abundance. Residual
DPY-27 is diffusely distributed within nuclei.
(C) sea-1(y356) suppresses fox-1 sex-1 le-
thality by restoring the levels of dosage com-
pensation proteins and permitting assembly
of the complex onto hermaphrodite X chro-
mosomes. Scale bars equal 5 m.eny that inherit this mitotically unstable array survive
(green), while progeny that fail to inherit the array die
(non-green) (Figure 1C). We sought mutations that per-
mitted fox-1 sex-1 hermaphrodites to live without the
array (non-green). These suppressor mutations are can-
didate ase(lf) mutations.
In principle, many classes of mutations could be re-
covered from this screen: loss-of-function (lf) mutations
in ASEs or in xol-1 and gain-of-function (gf) mutations
in XSEs. Among the suppressors isolated were one xol-
1(lf) allele and the allele y356, a loss-of-function muta-
tion shown below to disrupt an autosomal signal el-
ement.
Criteria for an Autosomal Signal Element
Autosomal signal elements would counter the X signal,
allowing us to predict the consequences of changing
the dose of a candidate ASE gene. Loss-of-function
mutations in an ASE gene should suppress the XX le-
thality caused by loss-of-function mutations in XSE
genes and enhance the XO lethality caused by increas-
ing XSE dose. Conversely, increasing ASE dose should
enhance the XX lethality from XSE loss-of-function mu-
tations and suppress the XO lethality from increasing
XSE dose. An ASE must act in a dose-dependent man-
ner in the zygote, because the zygotic X:A signal deter-
mines sex. As shown below, the gene defined by the
fox-1 sex-1 suppressor mutation y356 meets these cri-
teria, and moreover, it controls sex determination as
well as dosage compensation. We named the gene
sea-1 (signal element on an autosome).
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Lethality and Masculinization Caused
by Reducing XSE Dose
The mutation sea-1(y356) suppresses the XX-specific
lethality caused by double mutant combinations of known
XSEs, consistent with predictions for loss-of-function
mutations in an ASE gene. While all fox-1 sex-1 XX ani-
mals die, 52% of the sea-1; fox-1 sex-1 XX mutants
survive (Figure 3B). Suppression is recessive: all sea-
1(y356)/+; fox-1(y303) sex-1(y263) XX animals die (data
not shown).
In addition to sex-1 and fox-1, two other XSEs have
been identified: ceh-39 (J. Gladden and B.J.M., unpub-
lished) and sex-2 (Figure 3A) (C.Y. Loh and B.J.M., un-
published). While only 7% of ceh-39(y414) sex-1(y263)
doubly mutant hermaphrodites survive, 36% of sea-
1(y356); ceh-39(y414) sex-1(y263) triply mutant her-
maphrodites survive (Figure 3B). Moreover, while all
sex-2(y324) sex-1(y263) double mutants die, 73% of
sea-1(y356); sex-2(y324) sex-1(y263) triply mutant her-
maphrodites survive. Thus, sea-1 meets the first essen-
tial criterion for being an ASE.
sea-1(y356) suppresses the lethality of XX mutants
with reduced XSE dose by restoring binding of the dos-
age compensation complex to X chromosomes (Figure
2C). In fox-1 sex-1 double mutants, as in wild-type XO
embryos, the dosage compensation protein SDC-3 is
not present, and DPY-27 is diffusely distributed through-
out the nucleus rather than localized to X (Figures 2A
and 2B). In sea-1; fox-1 sex-1 embryos, both DPY-27
and SDC-3 can localize to X chromosomes. However,
not all SDC-3 and DPY-27 proteins are properly local-
ized to X, consistent with the partial suppression of le-
thality by sea-1(y356) and the finding that live sea-1;
fox-1 sex-1 animals have a mild dosage compensation
defect, a dumpy (Dpy) phenotype. Together, these ex-
periments demonstrate that sea-1 regulates dosage
compensation.
Mutations in X signal elements disrupt sex determi-
nation as well as dosage compensation, causing the
XX mutants to be masculinized. The rescued sea-1;
fox-1 sex-1 XX animals developed as hermaphrodites
rather than males, indicating that sea-1(y356) also sup-
pressed the sex determination defects caused by XSE
mutations. Thus, sea-1 acts in the known genetic hier-
archy to control both sex determination and dosage
compensation.
sea-1 Acts Upstream of the XX-Specific Gene
that Triggers Assembly of the Dosage
Compensation Complex on X
If sea-1 acts in a manner analogous to XSEs to control
sex determination and dosage compensation, it will act
upstream of sdc-2, the pivotal XX-specific gene that
induces hermaphrodite sexual development and trig-
gers assembly of the dosage compensation complex
on X (Figure 1A; Chu et al., 2002; Dawes et al., 1999;
Nusbaum and Meyer, 1989). Null alleles of sdc-2 cause
masculinization and block assembly of the dosage
compensation complex, causing all hermaphrodites to
die. sdc-2 acts just prior to the divergence of the sex
determination and dosage compensation pathways.
Unlike the equally severe lethality caused by fox-1 sex-1
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pigure 3. sea-1 Is an Autosomal Signal Element
A) Genetic map of the X chromosome showing the location of
SEs (ceh-39, fox-1, sex-2, and sex-1) and yDp14, which duplicates
t least two XSEs, fox-1 and ceh-39.
B–E) Viability of XX and XO animals with different XSE and ASE
onfigurations. The values given for n are the expected number of
he genotypic class in the absence of the observed lethality; for (B)
nd (D), n is equal to the number of embryos laid. Only the relevant
enotype is listed; the full genotype is in Experimental Procedures.
B) Suppression of hermaphrodite phenotypes by sea-1(y356). Loss
f sea-1 suppresses the phenotypes caused by all known XSE mu-
ations, including the XX-specific lethality resulting from the double
utant combinations fox-1 sex-1, ceh-39 sex-1, and sex-2 sex-1,
ut not the dosage compensation mutation sdc-2.
C) Dose-dependent enhancement of male lethality by sea-1(y356).
single copy of yDp14 kills 50% of males. This lethality is en-
anced by the loss of sea-1 and depends on the number of sea-1
opies present. The deficiency ccDf3 removes the sea-1 locus and
ehaves in a genetically similar manner to sea-1(y356), suggesting
hat the sea-1 mutation is null or near null.
D) Enhancement of hermaphrodite lethality by sea-1(+) overex-
ression. Decreasing the function of the XSE sex-1 by RNAi de-
reases hermaphrodite viability; extra copies of sea-1(+) on an ex-
rachromosomal array dramatically enhance this lethality.
E) Suppression of male lethality by sea-1(+) overexpression. The
ale lethality caused by one copy of the XSE duplication yDp14 is
artially suppressed by extra copies of sea-1(+).
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343Figure 4. sea-1 Encodes a T-Box Protein
(A) The predicted genomic and protein struc-
tures of sea-1 are diagrammed. The site to
which the SL1 trans-spliced RNA leader is
attached to the sea-1 mRNA is represented
on the DNA by an arrow. sea-1(y356) is a C
to T transition at nucleotide 97 after the likely
translational start site, replacing a glutamine
codon with an ochre stop codon at position
33. SEA-1 contains a T-box DNA binding do-
main in the C-terminal half.
(B) Western blot of wild-type, sea-1 mutant,
and sea-1(+) overexpressing embryonic ex-
tracts probed with anti-SEA-1 antibodies,
with a tubulin loading control. SEA-1 protein
is not detectable in sea-1(y356) mutant
embryo extract but is present in wild-type
extract and overexpressed in yIs61[sea-1(+)]
extract. The predicted size of wild-type SEA-1
is 42.7 kDa.
(C) Alignment of SEA-1 T-box domain with
T-box domains from other species. SEA-1 is
significantly diverged from other T-box pro-
teins. The SEA-1 T-box domain shares 27%
identity with that of mouse BRACHYURY and
frog VEGT. In contrast, the more conventional
T-box domain of the C. elegans MAB-9 protein
shares 52% identity with both BRACHYURY
and VEGT. Similarly, the T-box domains of
BRACHYURY and VEGT are 52% identical.double mutations, sdc-2 XX lethality was not sup-
pressed by sea-1(y356) (Figure 3B), demonstrating that
sea-1 acts upstream of sdc-2 in the genetic regulatory
hierarchy to control dosage compensation. Consistent
with this observation, sea-1(y356) cannot suppress the
lethality caused by loss-of-function mutations that dis-
rupt members of the dosage compensation complex,
such as dpy-27.
sea-1 Mutation Enhances the Male Lethality
Caused by Increasing XSE Dose
The wild-type function of an ASE is to promote the male
fate, and loss of ASE function should impair male de-
velopment. sea-1 has this predicted property. sea-
1(y356) alone does not cause lethality or any visible
phenotype in males, a result expected if ASEs act cu-
mulatively like XSEs. The cumulative nature of the X
signal minimizes the impact of reducing the dose of any
single element (Carmi and Meyer, 1999). However, sea-
1(y356) does enhance the partial male lethality caused
by the elevation of XSE dose. A single copy of yDp14,
which increases the X:A ratio by duplicating fox-1 and
ceh-39 (Figure 3A), kills 50% of males (Figure 3C; Carmi
and Meyer, 1999). Homozygous sea-1(y356) increases
yDp14/+ male lethality to 100% (Figure 3C). In this as-
say, the sea-1 deficiency ccDf3 behaved similarly to
sea-1(y356) (Figure 3C), establishing that sea-1(y356) is
a loss-of-function mutation.
sea-1 Acts in a Dose-Dependent Manner
sea-1 meets another criterion for an ASE: it acts in a
dose-dependent manner. Since ASEs communicate the
dose of autosomes, we expect that reducing the dose
of a single ASE to one copy will shift the perceived X:A
ratio enough to feminize mutants on the threshold be-tween the male and hermaphrodite fates. Consistent
with this prediction, sea-1(y356) dose dependently en-
hances the male lethality of yDp14/+. While 50% of
yDp14/+ males and 100% of yDp14/+; sea-1(y356)/
sea-1(y356) males die, only about 88% of yDp14/+; sea-
1(y356)/+ males die (Figure 3C). The range of pheno-
typic severity caused by sea-1(y356)/sea-1(y356), sea-
1(y356)/+, and +/+ in the sensitized yDp14/+ genetic
background indicates that worms can distinguish
among zero, one, and two doses of the wild-type sea-1.
sea-1 Acts in the Zygote
The sex of C. elegans is determined by the X:A signal
of the zygote rather than the mother. Therefore, an ASE
must function, at least in part, in the zygote. The experi-
ments described previously were conducted in a man-
ner to differentiate between the maternal and zygotic
contribution of sea-1. The following summary of these
experiments establishes that sea-1 acts zygotically,
consistent with its role as an ASE. In this description,
m represents the sea-1 maternal contribution and z the
zygotic contribution.
Heterozygous sea-1(y356)/+; fox-1 sex-1 hermaphro-
dites from homozygous sea-1(y356); fox-1 sex-1 moth-
ers were not viable, indicating that loss of the maternal
sea-1 contribution cannot suppress fox-1 sex-1, if the
zygote has a wild-type copy of sea-1 (m−z+ configura-
tion). In contrast, sea-1(y356)/+; fox-1 sex-1; yEx483
[Pdpy-30::sdc-2(+)] hermaphrodites did produce viable
non-green sea-1(y356); fox-1 sex-1 hermaphrodite self
progeny, showing that loss of the zygotic sea-1(+) con-
tribution suppresses fox-1 sex-1 mutant animals, re-
gardless of whether the mother has a wild-type sea-1 al-
lele (m+z− configuration). Although it was formally
possible that the maternal yEx483[Pdpy-30::sdc-2(+)]
Developmental Cell
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(A–C) Confocal images of wild-type, sea-1 mutant, and sea-1(+) overexpressing embryos at approximately the 20- to 30-cell stage, costained
with antibodies against SEA-1 (green) and SDC-3 (red) and with DAPI (blue), a DNA-intercalating dye.
(A) SEA-1 accumulates in nuclei of 20- to 100-cell wild-type embryos, the correct time to regulate xol-1. At the 30-cell stage, the dosage
compensation protein SDC-3 is present in nuclei but has not yet localized to the X chromosomes.
(B) SEA-1 protein is not detectable in sea-1(y356) mutant embryos; SDC-3 is unaffected.
(C) sea-1 is overexpressed in yIs61[sea-1(+)] embryos.
(D) sea-1 acts upstream of xol-1. Multiple copies of sea-1 on the integrated array yIs61 enhanced the weak XX-specific lethality caused by
sdc-2(RNAi). The enhancement of lethality was suppressed by a xol-1 mutation. n is the total number of embryos counted. Percent viability
is the number of adults relative to the number of embryos laid.
(E) Model for sea-1 action. Our cumulative data establish sea-1 to be an ASE that acts upstream in the sex determination hierarchy to activate
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345the X signal. Hence, the autosomal signal consists, at
xol-1 transcription.
(F) DIC images of gravid wild-type XX hermaphrodites, him-8 XX hermaphrodites, and SEA-1-overexpressing XX hermaphrodites carrying
yIs33[Pxol-l::lacZ], a transcriptional fusion between the xol-1 promoter and lacZ coding sequence, stained for β-galactosidase activity (Nicoll
et al., 1997). Expression of this reporter mimics endogenous xol-1 expression: β-galactosidase is produced in XO embryos but not XX
embryos. The him-8 mutation elevates X chromosome nondisjunction, resulting in w37% XO progeny compared to 0.2% XO progeny from
wild-type XX hermaphrodites. In 58% of yIs33[Pxol-l::lacZ]; him-8(-) hermaphrodites examined, at least one embryo showed dark staining,
indicating expression of Pxol-1::lacZ at high level (n = 53 adults containing 590 embryos). These darkly staining embryos are XO. The vast
majority of all other embryos (XX) showed no β-galactosidase staining. By contrast, in 87% of gravid yIs33[Pxol-l::lacZ]; him-8(+) XX hermaph-
rodites examined, more than 75% of the embryos showed either light or no β-galactosidase staining (n = 69 adults containing 1260 embryos).
None of the yIs33[Pxol-l::lacZ] hermaphrodites had any darkly staining embryos. Overexpression of sea-1 by the integrated yIs61[sea-1(+)]
array was sufficient to partially activate Pxol-1::lacZ expression in XX embryos. About 58% of yIs61[sea-1(+)]; yIs33[Pxol-l::lacZ] gravid
hermaphrodites contained at least one darkly staining XX embryo, and 25% of the other XX embryos showed medium to dark staining (n =
62 adults containing 917 embryos). Scale bars equal 5 m.
1927; Gluecksohn-Schoenheimer, 1944).array affected the phenotype of the zygote in this ex-
periment, the sea-1(y356)/+; fox-1 sex-1; yEx483 her-
maphrodites also produced +/+; fox-1 sex-1 progeny
(m+z+) that died as embryos or young larvae. There-
fore, maternal yEx483[Pdpy-30::sdc-2(+)] cannot res-
cue fox-1 sex-1 lethality in a sea-1(+) zygote and thus
is unlikely to affect the phenotype of the sea-1; fox-1
sex-1 siblings. We conclude that loss of sea-1 function
in the zygote is necessary and sufficient for suppres-
sion of fox-1 sex-1 mutants.
In addition, loss of sea-1 in the zygote enhances the
male lethality caused by yDp14. All yDp14/+; sea-
1(y356) males are dead, regardless of whether the
mother is yDp14/+; sea-1(y356) (m−z−) or yDp14/+;
sea-1(y356)/+ (m+z−). However, not all yDp14/+; sea-
1(y356)/+ males from yDp14; sea-1(y356) mothers are
dead, indicating that a homozygous sea-1(y356) muta-
tion in the mother is not sufficient to kill all male prog-
eny. Therefore, both suppression of fox-1 sex-1 her-
maphrodite lethality and enhancement of yDp14/+ male
lethality are determined by the zygotic genotype of
sea-1.
Increasing sea-1 Dose Has the Reciprocal
Consequence of Decreasing sea-1 Dose
For sea-1 to be a bona fide ASE, increasing its dose
should have the opposite effect of decreasing its dose:
increasing sea-1(+) dose should enhance the XX-spe-
cific lethality caused by loss of XSE function and
should reduce the XO-specific lethality caused by
increasing XSE dose. Since no chromosomal duplica-
tions of the sea-1 region existed, we cloned sea-1 as
described below and generated an extrachromosomal
array, yEx716[sea-1(+)], which contains multiple copies
sea-1(+). This sea-1(+) array enhanced the hermaphro-
dite lethality induced by sex-1 RNA interference (RNAi):
73% of wild-type hermaphrodites survived sex-1 RNAi
but less than 1% of hermaphrodite siblings carrying
yEx716[sea-1(+)] survived (Figure 3D). The converse is
also true: sea-1(+) arrays rescued the male lethality
caused by a single copy of the XSE duplication yDp14
(Figure 3E). In this experiment, only 20% of yDp14/+
males survived in the absence of the array, but the via-
bility was increased to 80% in the presence of the sea-
1(+) extrachromosomal array.
These genetic experiments demonstrate that sea-1
acts in a zygotic, dose-dependent manner to counterlast in part, of discrete genes that control both sex de-
termination and dosage compensation.
sea-1 Encodes a T-Box Transcription Factor
To elucidate the molecular nature of the autosomal sex
signal and determine whether the signal includes trans-
acting products or cis-acting sites, sea-1 was mapped
using single nucleotide polymorphisms (SNPs) and
then cloned by germline transformation rescue experi-
ments (Experimental Procedures and Table S1 in the
Supplemental Data available with this article online).
sea-1 resides between map positions –6.33 and –5.49
on the left side of LG II, in a 270 kb region spanned by
9 cosmids, with two gaps covered by YACs. The sea-1
interval contains 92 predicted open reading frames
(ORFs). Transgenic arrays containing each of the cosmids
spanning the sea-1 interval were tested for their ability
to rescue the enhancement of yDp14/+ male lethality
by sea-1(y356)/+ and by sea-1(y356)/sea-1(y356). The
F19B10 cosmid rescued these phenotypes. All rescuing
activity of F19B10 was attributed to the single PCR-
amplified ORF F19B10.9 (Table S1).
The wild-type product of F19B10.9 (called TBX-18 in
Wormbase) is predicted to encode a 376 amino acid
protein containing a C-terminal T-box DNA binding do-
main. Sequence analysis of F19B10.9 from the sea-
1(y356) mutant provided direct evidence that we cor-
rectly determined the molecular identity of sea-1. The
y356 lesion is a C to T transition 97 bases after the
putative translational start site of F19B10.9, changing
a glutamine codon to an ochre stop codon, which is
predicted to truncate the SEA-1 protein at amino acid
33 (Figure 4A). The molecular nature of the lesion is
consistent with genetic tests indicating that sea-
1(y356) is a loss-of-function allele (Figure 3C).
The T-box is a site-specific DNA binding domain
present in a large group of proteins involved in diverse
aspects of metazoan developmental regulation, includ-
ing the specification of primary germ layer identity, limb
development, and cell fate during organogenesis
(Kispert and Hermann, 1993; Showell et al., 2004). Many
T-box transcription factors have dose-sensitive pheno-
types, like the ASE T-box protein SEA-1. For example,
the founding member Brachyury (T) causes a shortened
tail phenotype in heterozygous mice and a more severe
phenotype in homozygous mice, including lethality ac-
companied by a missing posterior notochord and
mesoderm (Chesley, 1935; Dobrovolskaia-Zavadskaia,
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346SEA-1 Accumulates in Nuclei of Young Embryos
Consistent with the molecular identity of SEA-1 as a
T-box transcription factor, SEA-1 accumulates in nuclei
of young embryos, as indicated by immunofluores-
cence experiments with anti-SEA-1 antibodies (Figure
5A). Antibodies raised to an N-terminal peptide of SEA-1
recognized a 43 kDa band in Western blots of wild-type
embryonic extract, in agreement with the predicted size
of SEA-1 (Figure 4B). This band is more abundant in ex-
tract made from embryos carrying the chromosomally in-
tegrated yIs61[sea-1(+)] array, which has multiple copies
of sea-1(+), and is missing from sea-1(y356) mutant em-
bryonic extract, confirming the specificity of the anti-
body, the overexpression of SEA-1 from the yIs61[sea-
1(+)] array, and the loss of SEA-1 in the mutant. Consis-
tent with the Western blot, SEA-1 accumulates to
higher levels in overexpressing yIs61[sea-1(+)] embryos
and is absent from sea-1(y356) mutant embryos (Fig-
ures 5B and 5C).
Early expression of signal elements is key to their
function as regulators of the sex determination and
dosage compensation decision. Accumulation of SEA-1
becomes detectable by immunofluorescence in very
young embryos, before the 30-cell stage, and is no
longer detectable by the 100-cell stage. This temporal
pattern of SEA-1 accumulation is similar to that of
XSEs, which also accumulate prior to the 30-cell stage
and become greatly diminished in older embryos
(Carmi et al., 1998; Nicoll et al., 1997). Proper expres-
sion of xol-1, the direct target of the XSEs, is required
from the 30-cell stage through gastrulation: functional
XOL-1 is necessary for XO viability and sufficient for XX
lethality during this interval in development (Rhind et
al., 1995). XOL-1 prevents accumulation of SDC-2,
which triggers the assembly of the dosage compensa-
tion complex on the X chromosomes of XX embryos by
approximately the 40-cell stage (Dawes et al., 1999).
Since SEA-1 accumulation precedes both the formation
of the dosage compensation complex and the expres-
sion of xol-1, SEA-1 is present at the right time and
place to regulate the choice of sexual fate, potentially
by regulating xol-1.
sea-1 Is an Activator of xol-1 Transcription
The steps in the genetic pathway controlled by the au-
tosomal signal were not known. Theoretically, an ASE
could repress one or more XSE; however, SEA-1 is un-
likely to repress any of the known XSEs since sea-
1(y356) strongly suppresses all XSE null mutant combi-
nations. Like the XSEs, SEA-1 could regulate xol-1
expression directly or indirectly. Alternately, it could act
in parallel with xol-1 to regulate sdc-2. Distinguishing
among these possibilities is critical to understanding
how the autosomal signal regulates sex determination
and dosage compensation.
With few exceptions, T-box transcription factors are
activators of gene expression, although very few direct
targets of T-box genes are known (Tada and Smith,
2001). We first sought sea-1 targets using the consen-
sus in vitro binding site, the palindrome TTTCACACCT
AGGTGTGAAA (Kispert and Hermann, 1993), for the
founding T-box family member Brachyury to conduct
BLAST searches of promoters and entire cosmids of
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lthough most tested T-box proteins bind this se-
uence in vitro, sequence variants are found in the up-
tream regulatory regions of their targets, suggesting
hat in vivo conditions favor binding to variant sites
Tada and Smith, 2001). The BLAST searches identified
o consensus binding sites in genes of the sex determi-
ation and dosage compensation pathway. The T-box
NA binding domain in SEA-1 is quite diverged relative
o other T-box proteins (Figure 4C), suggesting that the
EA-1 DNA binding site has diverged sufficiently to be
nrecognizable by a simple BLAST search.
Taking a candidate gene approach, we asked
hether SEA-1 regulates xol-1 in vivo. Using a genetic
pproach, we showed that sea-1 acts upstream of xol-1
Figures 5D and 5E). Multiple copies of sea-1 on the
ntegrated array yIs61 enhanced the weak XX-specific
ethality caused by sdc-2(RNAi). The enhancement of
ethality was suppressed by a xol-1 mutation (Figure
D). While 65% of sdc-2(RNAi) XX embryos are viable,
nly 8% of yIs61; sdc-2(RNAi) XX embryos are viable.
xol-1 mutation restores viability to 74%, indicating
hat sea-1 functions upstream of xol-1 (Figure 5E).
xol-1 is regulated at both transcriptional and post-
ranscriptional levels (Carmi and Meyer, 1999; Nicoll et
l., 1997). To assess whether SEA-1 controls xol-1 at
he level of transcription, we assayed the effect of an
ncrease in sea-1 dose on the transcription of a lacZ
eporter controlled by the xol-1 promoter. Expression
f the integrated transgenic reporter yIs33[Pxol-1::lacZ]
imics expression of the endogenous xol-1 gene.
-galactosidase is expressed at high levels in XO but
ot XX embryos. If an ASE regulates xol-1, by definition
t must be an activator of xol-1 expression. We found
hat the increased dose of sea-1 provided by the integ-
ated array yIs61[sea-1(+)] activates expression of yIs33
Pxol-1::lacZ] in hermaphrodite embryos (Figure 5F).
oreover, quantitative RT-PCR analysis of xol-1 tran-
cript levels in yIs61[sea-1(+)] XX animals compared to
ild-type XX animals revealed a 2.1-fold increase (SEM
f 0.18) in transcript levels in the SEA-1-overexpressing
train. We have yet to find direct evidence of SEA-1
inding to the xol-1 promoter, but the latter two experi-
ents conclusively demonstrate that xol-1 is the target
direct or indirect) of SEA-1 and that SEA-1 activates
ol-1 transcription.
onclusions
n summary, sea-1 meets all the criteria for an autoso-
al element of the C. elegans sex determination signal.
emarkably, ASEs are highly analogous to XSEs. Loss
f sea-1 suppresses the XX-specific masculinization
nd lethality caused by reducing XSE dose and en-
ances the XO-specific lethality caused by increasing
SE dose. Increasing the dose of sea-1(+) has the re-
iprocal phenotype: it enhances the hermaphrodite sex
etermination and dosage compensation defects caused
y reducing XSE dose and suppresses the male lethal-
ty caused by increasing XSE dose. Moreover, sea-1
cts in a dose-dependent, zygotic manner. sea-1 is
hus the first identified component of the C. elegans
utosomal sex signal. sea-1 encodes a T-box transcrip-
ion factor, defining a role for this key class of cell fate
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347regulators in sex determination. SEA-1 activates xol-1
transcription, either directly or indirectly, establishing
that xol-1 acts as the master regulator to integrate both
X chromosome and autosomal signals to determine
sexual fate in C. elegans.
Drosophila melanogaster is the only other species
with a well-characterized X:A sex-determination signal,
although it uses a completely distinct set of genes and
molecular mechanisms to assess this signal (Cline and
Meyer, 1996). In flies, four XSEs activate transcription
of the single feminizing target gene Sex-lethal (Sxl). De-
spite extensive genetic screens, only one significant
ASE has been found. The ASE called deadpan (dpn)
represses transcription of Sxl, but repression by dpn is
not robust (Barbash and Cline, 1995; Younger-Shep-
herd et al., 1992). Unlike sea-1, deadpan plays essential
roles in other developmental processes, as do all fly,
but not worm, XSE genes. If the fly X:A denominator is
composed of other discrete loci, each is likely to have
a much weaker effect than dpn. In contrast, our recent
experiments have revealed two other distinct C. ele-
gans ASE genes, each at least similar in strength to
sea-1. The ASEs act cumulatively to control sex deter-
mination and dosage compensation (P. Nix, M.M.J.,
J.R.P., and B.J.M., unpublished). Thus, unlike in flies,
the C. elegans autosomal sex signal is composed of a
small set of discrete autosomal signal element genes
that oppose X signal element genes to control the
choice of sexual fate and the activation of dosage com-
pensation. Future experiments will determine whether
ASEs, like XSEs, function through diverse molecular
mechanisms and will reveal the molecular strategy by
which ASEs counter XSEs to determine sexual fate.
Analysis of sea-1 has already provided important an-
swers to the long-standing enigma of how small changes
in the concentration of dose-sensitive regulators can
be translated into different developmental fates.
Experimental Procedures
Mutagenesis
Progeny from EMS-mutagenized (Brenner, 1974) L4 fox-1 sex-1;
yEx483[dpy-30::sdc-2(+), myo-2::gfp] hermaphrodites were grown
semiclonally at 15°C to reduce the number of nonmutant escapers.
F1, F2, and F3 progeny, representing 4500 mutagenized haploid
genomes, were screened for live non-green hermaphrodites. Of 19
strong suppressors of fox-1 sex-1 lethality, 7 were not X-linked.
Two of these alleles, y356 and y379, mapped to discrete autosomal
loci and were analyzed further.
Hermaphrodite Viability
Hermaphrodite viability was assessed by counting embryos laid by
gravid hermaphrodites over a 4–8 hr period and then counting via-
ble adults 3–6 days later. Percent viability was calculated as the
(number of adults)/(number of embryos).
The strains fox-1(y303) sex-1(y263), sex-2(y324) sex-1(y263), and
ceh-39(y414) sex-1(y263) are inviable. These homozygous double
mutants were therefore maintained with the rescuing array yEx483
[Pdpy-30::sdc-2(+), myo-2::gfp], or the doubly mutant X chromo-
some was balanced by the szT1 chromosome. szT1 was identified
by its dominant Him and recessive lethal phenotypes. To assess
ceh-39(y414) sex-1(y263); yEx483 viability, progeny from rare non-
green escaper adults were scored. Viability counts for the lethal
null sdc-2(y74) allele were performed with the heterozygous strains
sdc-2(y74)/szT1 and sea-1(y356); sdc-2(y74)/szT1.Male Lethality
The effect of changing sea-1 dose on male viability was assessed
in the context of the X duplication yDp14, which has an extra copy
of fox-1 and at least one other XSE (Figure 3A). One copy of yDp14
kills 50% of males, as determined from the relative number of +/+;
him-8; unc-2 (Unc) and yDp14/+; him-8; unc-2 (non-Unc) male self
progeny from yDp14/+; him-8(e1489); unc-2(e55) hermaphrodites.
Out of 552 adult progeny counted, 212 yDp14/+ males were ex-
pected, but only 107 observed.
To determine whether reduction of sea-1 dose enhances the
male lethality of one copy of yDp14, progeny of yDp14/+; sea-
1(y356); him-8(e1489); unc-2(e55) hermaphrodites were examined.
Out of 723 adult progeny counted, 204 yDp14/+; sea-1; him-8;
unc-2 (non-Unc) males were expected but none found. To learn
whether this enhancement was dose sensitive, broods of yDp14/+;
mIn1 mIs14/sea-1; him-8; unc-2 hermaphrodites (1129 total adult
progeny counted) were compared with broods of yDp14/+; mIn1
mIs14/+; him-8; unc-2 control hermaphrodites (781 total adult
progeny counted). mIn1 mIs14 is a chromosome II balancer marked
with a recessive dpy-10 allele and the dominant myo-2::gfp marker.
Relative to the control broods, only 12% of the expected yDp14/+;
mIn1 mIs14/sea-1; him-8; unc-2 (non-Unc, green, non-Dpy) males
survived (20 observed, 168 expected).
To assess whether sea-1(y356) has a phenotype equivalent to the
deletion ccDf3, yDp14; sea-1; unc-2 hermaphrodites were crossed
with ccDf3/mIn1 mIs14 males (4135 total adult progeny counted)
and with control +/mIn1 mIs14 males (1323 total adult progeny
counted). 4% of the expected yDp14/+; sea-1/ccDf3; unc-2 (non-
Unc, non-green) males survived (3 observed, 72 expected), relative
to the number of yDp14/+; sea-1/+; unc-2 (non-Unc, non-green)
male progeny from the parallel control cross. These three viable
males were very sick, small, and slow-growing; therefore, it is un-
likely that these rare escapers truly indicate a less severe pheno-
type for sea-1(y356)/ccDf3 than for sea-1(y356)/sea-1(y356).
To measure the effect of sea-1 overexpression on male viability,
yEx716[sea-1(+)] males were crossed to yDp14; unc-2 hermaphro-
dites (1626 total adult progeny), and the number of viable yDp14/+;
unc-2 (non-green) males (142 observed, 736 expected) and
yDp14/+; unc-2; yEx716[sea-1(+)] (green) males (325 observed, 411
expected) was counted. The expected number of each class was
determined by crossing yEx716[sea-1(+)] males with N2 hermaph-
rodites to measure the transmission frequency of the array.
RNA Interference
RNAi against sex-1 and sdc-2 was performed as described (Ka-
math et al., 2000), except bacteria were grown in the presence of
100 g/ml ampicillin and 12.5 g/ml tetracycline. Of 4981 F1 em-
bryos laid by yEx716[sea-1(+)]; sex-1(RNAi) hermaphrodites, less
than 1% of the expected array-bearing progeny (4 observed, 1982
expected) survived, based on the transmission frequency of the
array in the absence of sex-1 RNAi.
SNP Mapping
sea-1(y356) was mapped using Snip-SNPs (single nucleotide poly-
morphisms that alter a restriction enzyme site) between CB4856,
the Hawaiian isolate of C. elegans (Koch et al., 2000), and N2, the
parental strain for sea-1. sea-1; fox-1 sex-1 hermaphrodites were
crossed with homozygous CB4856 males; the heterozygous male
cross progeny were crossed to sea-1; fox-1 sex-1 hermaphrodites.
Cross progeny hermaphrodites homozygous for sea-1 and fox-1
sex-1 may have acquired Hawaiian SNP alleles by recombination.
Multiple Snip-SNP loci were genotyped from a single recombi-
nant worm using a bulk worm lysate generated from the self-prog-
eny of that recombinant hermaphrodite (Wicks et al., 2001). 1 L of
lysate served as the template for a 25 l PCR reaction (0.4 M
each primer, 0.4 mM dNTPs, 1 U Roche Expand Long polymerase
mix, 1X Expand Long buffer #1). The entire reaction was digested
for 4 hr in a final volume of 30 l (5–10 U appropriate restriction
enzyme), half of which was run on a 2% NuSieve agarose gel.
Linkage of sea-1 to chromosome II was demonstrated by geno-
typing 17 recombinant hermaphrodites for 15 SNPs spanning the 5
autosomes. The recombinants were cross progeny from mating
y356/CB4856 II; fox-1 sex-1 X males with y356 II; fox-1 sex-1 X
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348hermaphrodites. y356 was unlinked to any of the SNPs on chromo-
somes I, III, IV, or V. 2/17 recombinants acquired Hawaiian alleles
at map positions LGII:0.12 and LGII:13.4 but retained the N2 allele
at LGII:–9.2. 1/17 acquired the Hawaiian allele at –9.2 but retained
N2 alleles at 0.12 and 13.4. This recombination data places y356
on the left side of chromosome II between –9.2 and 0.12.
The location of sea-1 was further narrowed to a 0.8 cM interval
by genotyping 166 additional recombinants at 15 additional SNP
loci between map positions –9.2 and 0.12. One recombinant ac-
quired Hawaiian alleles at map position –6.33 and all SNPs to its
left but not at –6.2 or any other SNPs to the right. Thus, y356 is
to the right of map position –6.33. Another recombinant acquired
Hawaiian alleles at –5.49 and all to its right. Therefore, y356 is to
the left of map position –5.49. Thus, y356 is in the interval bounded
on the left by –6.33 on YAC Y49F6b and on the right by –5.49 on
cosmid T24E12.
Transgene Arrays
To express sdc-2(+) independently of the sex signal, the array
yEx483 was made by coinjecting pTY975 Pdpy-30::sdc-2 (50 ng/
l), pRF4 rol-6(su1006) (100 ng/l), and pPD118.33 myo-2::gfp (50
ng/l) (from A. Fire) into wild-type worms. To make cosmid lines to
test rescue of sea-1(y356), individual cosmids (10–20 ng/l) were
coinjected with pPD118.33 myo-2::gfp (30 ng/l) into sea-1(y356)
hermaphrodites. yEx716[sea-1(+)] was made from a PCR product
of the genomic region corresponding to ORF F19B10.9. The prim-
ers used (JRP73: TAGTCATGACGTTCTTCCTGAAACTT and JRP74:
GTGACGGATGGAGAATAGTTGTATAT) amplify the entire region be-
tween the two neighboring ORFs, F19B10.8 and F19B10.2. sea-
1(y356) hermaphrodites were coinjected with this PCR product (2
ng/l), pPD118.33 myo-2::gfp (30 ng/l), and a mixture (100 ng/l)
of other cosmid and PCR product DNA that had been shown not
to rescue sea-1. yIs61[sea-1(+)] is an autosomal integrant of yEx71-
6[sea-1(+)], following UV irradiation (Frank et al., 2003). yIs33 is a
Pxol-1::lacZ reporter containing 2.8 kb of xol-1 upstream regulatory
sequence fused to the lacZ ORF and the 3# UTR from unc-54 to
stabilize the lacZ transcript (Nicoll et al., 1997).
Quantification of xol-1 Transcript Levels
Quantitative RT-PCR analysis (Van Gilst et al., 2005) of xol-1 tran-
script levels was performed on three independent cDNA prepara-
tions made from each of wild-type, him-8, and yIs61[sea-1(+)] em-
bryos. xol-1 transcript levels were normalized to nhr-64 transcript
levels.
SEA-1 Antibody
Rabbit anti-SEA-1 antibodies were raised (Covance, Inc.) and affin-
ity-purified against an N-terminal 21 amino acid peptide plus CG
linker, NQKYPQSAEEYHKVLCNYFIT (synthesized by David King).
The C terminus of this peptide is located 2 amino acids N-terminal
to the ochre stop codon introduced by the sea-1(y356) mutation.
Immunoblot Analysis
To prepare C. elegans embryonic extract, gravid hermaphrodites
were washed off plates with M9 and treated with hypochlorite to
obtain embryos. Embryos were boiled in an equal volume of SDS-
PAGE buffer for 10 min and spun for 1 min at 16,000 × g. The
supernatant was fractionated through a 10% SDS-PAGE gel. The
Western blot was performed with rabbit anti-SEA-1, mouse anti-
tubulin (iCN), horseradish peroxidase-conjugated donkey anti-rab-
bit, (Jackson ImmnunoResearch Labs), and horseradish peroxi-
dase-conjugated donkey anti-mouse (Jackson ImmnunoResearch
Labs) antibodies.
Immunofluorescence Microscopy
sea-1, wild-type, and yIs61[sea-1(+)] embryos were prepared as de-
scribed (Severson et al., 2000) but were fixed for 10 min in room
temperature ethanol, and the slides were incubated with antibodies
overnight at 4°C. The following antibodies were used: rabbit anti-
SEA-1, rat anti-SDC-3 (P. McDonel, B.J.M.), FITC-conjugated goat
anti-rabbit (Jackson ImmnunoResearch Labs), and Cy3-conjugated
donkey anti-rat (Jackson ImmnunoResearch Labs). At least 500
embryos of each genotype were scored.
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afox-1 sex-1, wild-type, and sea-1; fox-1 sex-1 embryos were pre-
ared as described (Chuang et al., 1994), except 2% paraformalde-
yde was used in the fixative and the embryos incubated in sec-
ndary antibodies overnight at room temperature. The following
ntibodies were used: rabbit anti-DPY-27 (Chuang et al., 1994), rat
nti-SDC-3 (P. McDonel, B.J.M.), FITC-conjugated goat-anti-rabbit
Jackson ImmnunoResearch Labs), and Cy-3-conjugated donkey
nti-rat, diluted (Jackson ImmnunoResearch Labs). At least 2000
mbryos of each genotype were scored.
All embryos were mounted in VectaShield (Vector Laboratories,
nc) containing 1 g/ml diamidinophenylindole (DAPI). All fluores-
ent images were obtained on a Leica TCS NT confocal micro-
cope.
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